Analyses / LRCX
Up 4.97% today on chip sector momentum, but trading 26% below 52W high amid stretched multiples and insider selling.
A free account reveals LRCX's entry zone, price target & stop loss. Full 1-week to 1-year price forecasts are included with Pro.
The Thesis
▲ Bull Case
LRCX is the premier wafer fab equipment play with 48.7% gross margins and 32% operating leverage. Chip demand (AI, advanced nodes) drives multi-year capex cycles. 22.4% 5Y EPS CAGR and 12.9% 5Y revenue growth demonstrate durable demand. Recent sector rally reflects confidence in memory/logic cycle recovery. Strong balance sheet (2.2x current ratio) supports dividend + buybacks.
▼ Bear Case
Forward P/E of 74.6x and P/S of 21.7x are elevated even for a quality compounder. Price-to-FCF of 73.9x suggests limited margin of safety. Stock is 26% below 52W high ($438.50), signaling profit-taking. Insider selling dominates (115 sells vs 44 buys; 1.45M shares sold vs 1.13M bought). Capex cycles are cyclical; a China slowdown or inventory correction could compress multiples further. Only 0.32% dividend yield despite 21.4% payout ratio.
Valuation
overvalued — score 62/100
LRCX trades at significant premium to semiconductor averages. While 22.4% 5Y EPS growth and 48.7% gross margins justify a premium, forward P/E of 74.6x and P/S of 21.7x leave little room for disappointment. Price-to-FCF of 73.9x is stretched. Fair value appears $300-330 in a base case; current $322 reflects optimism priced in.
Technical Levels
Support · $310.00 (1M breakout base) · $295.00 (Stop-loss / 20-day MA approx) · $280.00 (Bear case target; cycle trough)
Resistance · $330.00 (Day high; near-term ceiling) · $350.00 (1M resistance; base case target) · $380.00 (Bull case target; psychological) · $438.50 (52W high; strong resistance)
RSI: Not provided in Finnhub data
Financial Health
Score 88/100. Balance sheet is fortress-like: 2.21x current ratio, 1.49x quick ratio, no disclosed debt stress. Operating + net margins north of 30% underpin financial flexibility. Insider selling (115 vs 44 buys) is only minor concern; does not suggest distress.
Catalysts
| Q2 Earnings (expected next 4-6 weeks) | Likely late April/early May | EPS/revenue beat could re-rate multiple to 75-80x forward P/E; miss risks 5-10% pullback. |
| Capex Guidance from major customers (TSMC, Samsung, Intel calls) | Ongoing; Q2 earnings season | Strong forward bookings = bull signal; weak guidance = bear case trigger. |
| Memory oversupply / inventory correction narrative | Q2-Q3 2024 risk | If DRAM/NAND inventory high, capex orders could stall; stock could drop to $290-300. |
| China policy / geopolitical headwinds | Ongoing | Sanctions or export controls could disrupt capex cycles; modest 2-5% downside risk. |
| AI narrative evolution | Continuous | If AI capex stalls or shifts to software, fab capex slows; bull case at risk. |
Risk Flags
See LRCX's full trade plan — free
Create a free account to unlock the exact entry, target, and stop — plus run live analysis on any of 5,000+ tickers. No card required.
Unlock LRCX free →Recent News
- 2 Cash-Heavy Stocks to Target This Week and 1 We Turn DownYahoo
- Intel, KLA Corporation, Lam Research, Marvell Technology, and Micron Shares Skyrocket, What You Need To KnowYahoo
- Looking for a Growth Stock? 3 Reasons Why Lam Research (LRCX) is a Solid ChoiceYahoo
- Is AMAT's Installed Base Business Built for Long-Term Growth?Yahoo
- 5 Memory Stocks to Sell as Record Rally FaltersBenzinga
You've read your 2 free analyses
Create a free account for unlimited analyses — every name on the page, plus live tools on 5,000+ tickers. No card required.
Read the full LRCX analysis — free →Free to read · 2 analyses every 30 days without an account
More Analyses
LRCX FAQ
Is LRCX a buy right now?
Lam Research Corp's current read is a momentum_pullback_within_bull_run setup with 65 confidence over a 3-6 months horizon. Valuation: overvalued. See the full bull and bear case above, or run a live analysis for the exact entry, target and stop.
Is LRCX overvalued?
overvalued (valuation score 62/100). LRCX trades at significant premium to semiconductor averages. While 22.4% 5Y EPS growth and 48.7% gross margins justify a premium, forward P/E of 74.6x and P/S of 21.7x leave little room for disappointment. Price-to-FCF of 73.9x is stretched. Fair value appears $300-330 in a base case; current $322 reflects optimism priced in.
What are the risks of buying LRCX?
Forward P/E of 74.6x and P/S of 21.7x are elevated even for a quality compounder. Price-to-FCF of 73.9x suggests limited margin of safety. Stock is 26% below 52W high ($438.50), signaling profit-taking. Insider selling dominates (115 sells vs 44 buys; 1.45M shares sold vs 1.13M bought). Capex cycles are cyclical; a China slowdown or inventory correction could compress multiples further. Only 0.32% dividend yield despite 21.4% payout ratio.